Microbial testing laboratories often face challenges such as genetic drift, variability in results, and the need for extensive preparation. These issues can lead to inconsistent results and increased ...
Ensuring pharmaceutical safety and efficacy hinges on rigorous quality control (QC). By identifying potential microbial contaminants early in drug development and production, microbial QC tests ...
A straightforward path toward regulatory compliance, data integrity, and computer systems validation
Microbial testing, analysis and environmental monitoring is fundamental to safe pharmaceutical manufacturing. Regulatory agencies require that the many components of the system implemented, from ...
Microbial contamination threatens food safety, and traditional microbial risk assessment methods struggle with complex supply chains and microbial diversity. This paper reviews emerging detection ...
Experts in Belgium have given reasons why they believe a second analysis is not needed when doing microbiological testing. The Scientific Committee of the Federal Agency for the Safety of ...
The Microbiological Risk Classification and Assessment tool (MiRCA) is a valuable instrument elaborated by the European Directorate for the Quality of Medicines & HealthCare (EDQM) for evaluation of ...
According to MarketsandMarkets™, the Rapid Microbiology Testing Market is projected to grow from about USD 5.69 billion in ...
Pediatric ENT infections are prevalent and one of the most common reasons for antibiotic prescriptions. Turnaround times of conventional culturing assays are long leading to poor clinical management ...
Recent studies in this field have indicated microbial cell-free DNA (mcfDNA) testing as a viable assay capable of identifying pathogens from the bloodstream. However, this technique has not been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results